Neuroblastoma can be treatable, but the likelihood of successful treatment depends heavily on the risk group the patient falls into.
There are three main risk groups for neuroblastoma: low risk, intermediate risk, and high risk.
-
Low-risk and Intermediate-risk Neuroblastoma: These groups generally have a good prognosis, with a high chance of being cured.
-
High-risk Neuroblastoma: This is the most challenging form of the disease and can be difficult to cure.
Therefore, while neuroblastoma is potentially treatable, the success of treatment varies significantly based on the specific characteristics of the cancer and the patient's risk group.
